GLP-1 Drugs and Babies

It seems to be taking a long time for science to sort out exactly what is going on with the relationship between the GLP-1 genre of weight-loss medications and the creation of new humans. This is partly because deliberate experimentation would be unethical. Researchers can’t take a bunch of women who are pregnant or hope to be, and deliberately administer potentially harmful substances to them.

Scientists who want the knowledge are required to wait patiently for the statistics to become apparent among women who have accidentally found themselves in this situation, or who have knowingly and purposely conceived despite being cautioned against it.

An earlier post looked at the two main situations that provided information in earlier years. In some cases, weight loss alone can facilitate conception, and that includes women being treated with Ozempic or similar drugs. But just because this effect was noticed did not imply that the combination of pregnancy and these meds could be recommended. At the same time, unintentional pregnancies were occurring because the drugs might indirectly cause a patient’s birth control pills to be diluted or expelled.

The GLP-i meds purposely delay stomach emptying, so the user does not experience hunger to the same degree as previously, or as soon. Anything consumed stays in the stomach longer than before, which is not particularly desirable for other reasons.

Additionally, the meds commonly cause vomiting, which could also lead to something quite significant, like an unplanned pregnancy because the birth control pills are vomited up too. One way or another, the absorption factor is affected.

Dr. Phillip Kadaj, for example, has said,

If the hormones in birth control pills aren’t being fully absorbed because of the delayed emptying from semaglutide, there’s a chance that the pill may not be quite as effective.

This is quite an understatement when the possible outcome might result in setting up an online “want list” for baby shower gifts and planning a gender-reveal party. It is not a decision to be lightly made. Meanwhile, animal studies have indicated the possibility of unfavorable outcomes like miscarriage and birth defects. Furthermore, the risk incurred by breastfeeding with these drugs present is still a mystery.

One or all?

Currently, it seems that only tirzepatide might, in and of itself, hinder the effectiveness of oral contraception. But all drugs of this class can potentially cause vomiting, and thus the expulsion of birth control pills. And while this type of medication could increase the potential for an unplanned pregnancy, it could also threaten that pregnancy with as-yet-unknown damage. For one thing, maternal weight loss is not usually recommended when a baby is trying to develop inside, needing resources whose availability, or lack thereof, will affect its entire subsequent life.

As is so often the case, there is not enough research yet to really nail down the answer. The sticking point is that among the hormonal and non-hormonal birth control methods, no other current method is influenced by changes in the digestive system. Some doctors don’t say enough about this whole area of risk, while others take a conservative stand and advise patients to start using condoms several weeks before starting a course of weight-loss drugs.

(To be continued…)

Your responses and feedback are welcome!

Source: “Is There a Connection Between Semaglutide (Ozempic) and Birth Control?,” Healthline.com, 09/01/23
Source: “What to Know Before Taking Obesity Drugs While on Birth Control,” Health.com, 10/24/23
Image by Alick Sung/Attribution 2.0 Generic

Leave a Reply

Your email address will not be published. Required fields are marked *

FAQs and Media Requests: Click here…

Profiles: Kids Struggling with Weight

Profiles: Kids Struggling with Obesity top bottom

The Book

OVERWEIGHT: What Kids Say explores the obesity problem from the often-overlooked perspective of children struggling with being overweight.

About Dr. Robert A. Pretlow

Dr. Robert A. Pretlow is a pediatrician and childhood obesity specialist. He has been researching and spreading awareness on the childhood obesity epidemic in the US for more than a decade.
You can contact Dr. Pretlow at:

Presentations

Dr. Pretlow’s invited presentation at the American Society of Animal Science 2020 Conference
What’s Causing Obesity in Companion Animals and What Can We Do About It

Dr. Pretlow’s invited presentation at the World Obesity Federation 2019 Conference:
Food/Eating Addiction and the Displacement Mechanism

Dr. Pretlow’s Multi-Center Clinical Trial Kick-off Speech 2018:
Obesity: Tackling the Root Cause

Dr. Pretlow’s 2017 Workshop on
Treatment of Obesity Using the Addiction Model

Dr. Pretlow’s invited presentation for
TEC and UNC 2016

Dr. Pretlow’s invited presentation at the 2015 Obesity Summit in London, UK.

Dr. Pretlow’s invited keynote at the 2014 European Childhood Obesity Group Congress in Salzburg, Austria.

Dr. Pretlow’s presentation at the 2013 European Congress on Obesity in Liverpool, UK.

Dr. Pretlow’s presentation at the 2011 International Conference on Childhood Obesity in Lisbon, Portugal.

Dr. Pretlow’s presentation at the 2010 Uniting Against Childhood Obesity Conference in Houston, TX.

Food & Health Resources